[Efficacy of clinical pathways in infectious diseases].
作者信息
Ishida Tadashi
机构信息
Department of Respiratory Medicine, Kurashiki Central Hospital.
出版信息
Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:564-8.
PMID:17455682
Abstract
摘要
相似文献
1
[Efficacy of clinical pathways in infectious diseases].
Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:564-8.
2
[The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].[日本呼吸学会成人社区获得性肺炎管理指南]
Nihon Rinsho. 2003 Feb;61 Suppl 2:677-81.
3
Community acquired pneumonia.社区获得性肺炎
Med Health R I. 2010 Jul;93(7):196-200.
4
[Preventive measures for drug resistant bacteria by guidelines].[指南中关于耐药菌的预防措施]
Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:531-3.
5
6
BTS guidelines for the management of community acquired pneumonia in adults: update 2009.英国胸科学会成人社区获得性肺炎管理指南：2009年更新版
Thorax. 2009 Oct;64 Suppl 3:iii1-55. doi: 10.1136/thx.2009.121434.
7
[Treatment of community acquired pneumonia].[社区获得性肺炎的治疗]
Orv Hetil. 2004 May 30;145(22):1189-92.
8
Treatment of community-acquired pneumonia Down Under versus the United States: is it really that different?澳大利亚与美国社区获得性肺炎的治疗：真的有那么大差异吗？
Clin Infect Dis. 2008 May 15;46(10):1522-4. doi: 10.1086/586750.
9
[Switch therapy for community acquired pneumonia].
Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:326-30.
10
Ralstonia pickettii community-acquired pneumonia in Cambodia.柬埔寨嗜麦芽窄食单胞菌社区获得性肺炎
Int J Tuberc Lung Dis. 2010 Dec;14(12):1653-4.
Zotero 插件